FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282969329> ?p ?o ?g. }

• W4282969329 endingPage "106903" @default.
• W4282969329 startingPage "106903" @default.
• W4282969329 abstract "Anagrelide (ANA) is a platelet-specific cytoreductive agent utilized in the guideline-directed management of high-risk essential thrombocythemia. In the context of polycythemia vera (PV), ANA is occasionally employed in clinical practice, although data has not consistently demonstrated a benefit to targeting a platelet goal as a therapeutic endpoint. The aim of the current study was to delineate the patterns of ANA use in PV, and to describe outcomes and toxicities. Within a multi-center cohort of 527 patients with PV, 48 received ANA (9 excluded for absent data). 27 (69.2%) had high-risk PV, 10 (25.6%) had prior thrombosis, and none had extreme thrombocytosis, acquired von Willebrand disease, and/or documented resistance to hydroxyurea. While ANA effectively lowered median platelet count, 43.5% of patients had an unresolved thrombocytosis at time of ANA discontinuation. Treatment-emergent adverse events—including headaches, cardiac palpitations and arrhythmias, nausea, vomiting and/or diarrhea—led to ANA discontinuation in 76.9% of patients. Further, three patients experienced arterial thromboses during a median duration of 27.5 months of ANA therapy. In conclusion, this study highlights ANA’s restrictive tolerability profile which, compounded by the absence of clear advantage to strict platelet control in PV, suggests the use of ANA should be limited in this setting." @default.
• W4282969329 created "2022-06-17" @default.
• W4282969329 creator A5006372952 @default.
• W4282969329 creator A5011469908 @default.
• W4282969329 creator A5015755664 @default.
• W4282969329 creator A5017514064 @default.
• W4282969329 creator A5024962862 @default.
• W4282969329 creator A5028207893 @default.
• W4282969329 creator A5039057642 @default.
• W4282969329 creator A5047764826 @default.
• W4282969329 creator A5052288829 @default.
• W4282969329 creator A5065098368 @default.
• W4282969329 creator A5065621786 @default.
• W4282969329 creator A5071257161 @default.
• W4282969329 creator A5072336042 @default.
• W4282969329 creator A5085185312 @default.
• W4282969329 creator A5088994182 @default.
• W4282969329 date "2022-08-01" @default.
• W4282969329 modified "2023-10-16" @default.
• W4282969329 title "Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database" @default.
• W4282969329 cites W1484059621 @default.
• W4282969329 cites W1964863089 @default.
• W4282969329 cites W1968468753 @default.
• W4282969329 cites W1979832242 @default.
• W4282969329 cites W1980972742 @default.
• W4282969329 cites W1990387953 @default.
• W4282969329 cites W2025614458 @default.
• W4282969329 cites W2051259791 @default.
• W4282969329 cites W2059649875 @default.
• W4282969329 cites W2069651950 @default.
• W4282969329 cites W2072881492 @default.
• W4282969329 cites W2076259108 @default.
• W4282969329 cites W2092484653 @default.
• W4282969329 cites W2122395736 @default.
• W4282969329 cites W2123587611 @default.
• W4282969329 cites W2336835135 @default.
• W4282969329 cites W2339658711 @default.
• W4282969329 cites W2764282137 @default.
• W4282969329 cites W2765738369 @default.
• W4282969329 cites W2775863185 @default.
• W4282969329 cites W2790003237 @default.
• W4282969329 cites W2908363193 @default.
• W4282969329 cites W2948784783 @default.
• W4282969329 cites W3003423609 @default.
• W4282969329 cites W3004590385 @default.
• W4282969329 cites W3008905509 @default.
• W4282969329 cites W3028462752 @default.
• W4282969329 cites W3047954567 @default.
• W4282969329 cites W3095808680 @default.
• W4282969329 cites W4229976500 @default.
• W4282969329 doi "https://doi.org/10.1016/j.leukres.2022.106903" @default.
• W4282969329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35717689" @default.
• W4282969329 hasPublicationYear "2022" @default.
• W4282969329 type Work @default.
• W4282969329 citedByCount "0" @default.
• W4282969329 crossrefType "journal-article" @default.
• W4282969329 hasAuthorship W4282969329A5006372952 @default.
• W4282969329 hasAuthorship W4282969329A5011469908 @default.
• W4282969329 hasAuthorship W4282969329A5015755664 @default.
• W4282969329 hasAuthorship W4282969329A5017514064 @default.
• W4282969329 hasAuthorship W4282969329A5024962862 @default.
• W4282969329 hasAuthorship W4282969329A5028207893 @default.
• W4282969329 hasAuthorship W4282969329A5039057642 @default.
• W4282969329 hasAuthorship W4282969329A5047764826 @default.
• W4282969329 hasAuthorship W4282969329A5052288829 @default.
• W4282969329 hasAuthorship W4282969329A5065098368 @default.
• W4282969329 hasAuthorship W4282969329A5065621786 @default.
• W4282969329 hasAuthorship W4282969329A5071257161 @default.
• W4282969329 hasAuthorship W4282969329A5072336042 @default.
• W4282969329 hasAuthorship W4282969329A5085185312 @default.
• W4282969329 hasAuthorship W4282969329A5088994182 @default.
• W4282969329 hasConcept C126322002 @default.
• W4282969329 hasConcept C141071460 @default.
• W4282969329 hasConcept C151730666 @default.
• W4282969329 hasConcept C177713679 @default.
• W4282969329 hasConcept C187212893 @default.
• W4282969329 hasConcept C197934379 @default.
• W4282969329 hasConcept C2778375690 @default.
• W4282969329 hasConcept C2778715236 @default.
• W4282969329 hasConcept C2778837598 @default.
• W4282969329 hasConcept C2779343474 @default.
• W4282969329 hasConcept C2779788118 @default.
• W4282969329 hasConcept C2780829020 @default.
• W4282969329 hasConcept C2781057849 @default.
• W4282969329 hasConcept C71924100 @default.
• W4282969329 hasConcept C86803240 @default.
• W4282969329 hasConcept C89560881 @default.
• W4282969329 hasConceptScore W4282969329C126322002 @default.
• W4282969329 hasConceptScore W4282969329C141071460 @default.
• W4282969329 hasConceptScore W4282969329C151730666 @default.
• W4282969329 hasConceptScore W4282969329C177713679 @default.
• W4282969329 hasConceptScore W4282969329C187212893 @default.
• W4282969329 hasConceptScore W4282969329C197934379 @default.
• W4282969329 hasConceptScore W4282969329C2778375690 @default.
• W4282969329 hasConceptScore W4282969329C2778715236 @default.
• W4282969329 hasConceptScore W4282969329C2778837598 @default.
• W4282969329 hasConceptScore W4282969329C2779343474 @default.
• W4282969329 hasConceptScore W4282969329C2779788118 @default.

• next